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Abstract
The functional importance of sex steroid hormones (testosterone and estrogens), derived from 
extragonadal tissues, has recently gained significant appreciation. Circulating 
dehydroepiandrosterone (DHEA) is peripherally taken up and converted to testosterone by 313-
hydrox- ysteroid dehydrogenase (HSD) and 1713-HSD, and testosterone in turn is irreversibly 
converted to estrogens by aromatase cytochrome P-450 (P450arom). Although sex steroid 
hormones have been implicated in skeletal muscle regulation and adaptation, it is unclear whether 
skel- etal muscles have a local steroidogenic enzymatic machinery capable of metabolizing 
circulating DHEA. Thus, here, we investigate whether the three key steroidogenic enzymes (313-
HSD, 1713-HSD, and P450arom) are present in the skeletal muscle and are capable of generating 
sex steroid hormones. Consistent with our hypothesis, the present study demonstrates mRNA and 
protein expression of these enzymes in the skeletal muscle cells of rats both in vivo and in culture 
(in vitro). Importantly, we also show an intracellular formation of testosterone and estradiol from 
DHEA or testosterone in cultured muscle cells in a dose-dependent manner. These findings are 
novel and important in that they provide the first evidence showing that skeletal muscles are 
capable of locally synthesizing sex steroid hor- mones from circulating DHEA or testosterone. 
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SEX STEROID HORMONES ARE SECRETED mainly by the ovary, testis, 
and adrenal cortex and regulate diverse physiological processes 
of target tissues, including those of the reproductive tissues, 
bone, liver, cardiovascular tissues, brain, and skeletal muscles 
(37). Dehydroepiandrosterone (DHEA) and its sulfate-bound 
form (DHEA-S), secreted mainly by the adrenal gland and 
ovary, are the most abundant hormones in humans and other 
mammals and, in peripheral tissues, are important precursors of 
sex steroid hormones (19, 23). Thus DHEA plays a critical 
physiological role for peripheral tissues in maintaining steroi- 
dogenesis in that it is one of the available precursors converted 
to testosterone and estrogens (19, 22, 23). The biosynthesis of 
active androgens and estrogens from DHEA is achieved by 
three steroidogenesis-related enzymes (22). Testosterone is 
synthesized through metabolism of DHEA by 313-hydroxy- 
steroid dehydrogenase (313-HSD) and 1713-HSD, and in turn, 
estrogens are converted from androgens catalyzed by aro- 
matase cytochrome P-450 (P450arom). The physiological bal- 
ance between sex steroid hormones is largely controlled by 
aromatase (8). P450arom is a product of a single gene, whereas 
there are several types of 1713-HSDs, which are each a product 
of a distinct gene. Twelve different 1713-HSDs sites on the 
chromosome have been identified and in humans; so far, 10 
different 1713-HSDs have been cloned, 1–5, 7, 8, 10, 11, and 12 
(29). The 1713-HSDs differ in tissue distribution, catalytic 
preferences, substrate specificity, subcellular localization, and 
mechanisms of regulation. Rat 1713-HSD type I also efficiently 
converts androstenedione to testosterone (34). 
The skeletal muscle is a sex steroid-sensitive tissue in that it 
expresses receptors for both androgen and estrogen (11, 25). 
Testosterone and estradiol affect growth, strength, metabolism, 
and antioxidants in the skeletal muscle (16, 17, 35, 39, 40). 
Administration of testosterone has been reported to induce an 
increase in muscle strength with accretion of protein synthesis 
in the muscle (46). Deficiency of sex steroid hormones leads to 
retardation in skeletal muscle development, and long-term 
administration of DHEA promotes muscle strength and mass in 
humans (30, 48). Reports on the effects of estrogen replace- 
ment therapy on muscular strength (40) are contradictory; 
whereas some studies have attributed it to increased muscle 
strength, others report that it (estrogen) does not (3) increase 
muscle strength. To date, it is unclear whether sex steroid 
hormones acting on skeletal muscle are locally produced by 
steroidogenesis-related enzymes. Because DHEA is present in 
high amounts in circulation and is peripherally converted to 
testosterone and estrogens in most tissues, it is likely also 
converted locally by steroidogenesis-related enzymes (313- and 
1713-HSD and P450arom) into active sex steroid hormones in 
skeletal muscles (21). 
For this reason, we hypothesized that steroidogenesis-related 
enzymes, including 313-HSD, 1713-HSD, and P450arom, are 
present in the skeletal muscle and locally synthesize sex steroid 
hormones from circulating DHEA. Thus, in the present study, we 
examined whether these enzymes (mRNA and protein) are 1) 
expressed, 2) active, and 3) capable of synthesizing sex steroid 
hormones in the skeletal muscle of adult male rats in vivo and in 
vitro. Moreover, we investigated whether mRNA levels of steroi- 
dogenic enzymes are differentially expressed in different skeletal 
muscle types, i.e., gastrocnemius (intermediate  fi  soleus 
(mainly slow fi        and plantaris (mainly fast fi       muscles of 
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rat, because there are three types of skeletal muscles, namely type 
I (slow-twitch fi type IIA (intermediate of slow and fast- 
twitch fi and type IIB (fast-twitch fi which have distinct 
contractile, metabolic, and vascular properties. 
METHODS 
Animals. Ten 10-wk-old Sprague-Dawley (SD) male rats were 
obtained from Charles River Japan (Yokohama, Japan) and used in 
this study according to the Guiding Principles for the Care and Use of 
Animals, based on the Helsinki Declaration. After the rats had been 
adequately anesthetized with diethyl ether, the gastrocnemius, soleus, 
and plantaris skeletal muscles and testis, brain, liver, and kidney were 
rapidly excised and washed thoroughly with cold saline to remove 
contaminating blood, processed, and snap-frozen in liquid nitrogen. 
These tissue samples were stored at -80°C and were later analyzed 
for 1) mRNA expression of P450arom, 313-HSD, and 1713-HSD type 
I by semiquantitative RT-PCR and real-time quantitative RT-PCR 
analysis; 2) protein expression of P450arom and 1713-HSD type I by 
Western blotting analysis and immunofluorescence staining; and 3) 
total testosterone and estradiol levels by sandwich enzyme immuno- 
assay (EIA) analysis. All of the above and subsequent experimental 
protocols in the present study were approved by the Committee on 
Animal Research at the University of Tsukuba. 
Cells. Myoblasts of skeletal muscle were isolated from 2- to 3-
day-old SD rats, as described previously (42). After confluent 
proliferation for 2 days, myoblast cells were incubated on fibronectin- 
coated dishes in DMEM-Ham’s F12 medium supplemented with 2 ml 
of DMEM + 2% horse serum (Cell Garage, Hokkaido, Japan) for 7 
days, differentiated to develop myotubes, and then used for further 
experiments. Briefly, muscle cells were exposed to either vehicle-only 
(control, in 95% air-5% CO2), DHEA, or testosterone for 24 h and 
then harvested for analysis. DHEA (Wako Pure Chemical Industries, 
Osaka, Japan) and testosterone (Sigma, St. Louis, MO) were dissolved 
in 95% ethanol. The following doses were used for both DHEA and 
testosterone: 10, 100, 300, and 500 µM. Following treatment, cell 
samples were harvested and stored at -80°C to analyze mRNA 
expression of P450arom, 313-HSD, and 1713-HSD type I by semiquan- 
titative RT-PCR and intracellular levels of total testosterone and 
estradiol by EIA analysis. 
Reverse transcription. Total tissue RNA was isolated using Isogen 
(Nippon Gene; Toyama, Japan), according to our previous studies 
(13). Total tissue RNA (2 µg) was primed with 0.05 µg of oligo 
d(pT)12–18 and reverse transcribed by Omniscript reverse transcriptase 
using a cDNA synthesis kit (Qiagen) (15). The reaction was per- 
formed at 37°C for 60 min. 
PCR. Semiquantitative PCR was performed according to the 
method described in our previous report (14) with minor modifica- 
tions. Each PCR reaction contained 10 mM Tris (pH 8.3), 50 mM 
KCl, 1.5 mM MgCl2, dNTP at 200 mM each, and gene-specific 
primers at 0.5 µM each, and 0.025 U/µl ExTq polymerase (Takara, 
Shiga, Japan). The gene-specific primers were synthesized according 
to the published cDNA sequences for each of the following: 
P450arom (12), 313-HSD (36), 1713-HSD type I (10), and 13-actin (32) 
mRNA. Because 313-HSD has four different isoforms (types I–IV) in 
rats (36), in the present study we designed PCR primers that would 
detect both type I and type II of 313-HSD. The sequences of the 
oligonucleotides were as follows: P450arom forward: 5'-ATTT- 
TCGCTGAGAGACGTGGAG-3', reverse: 5'-ATTGGGCTTGGG- 
GAAATACTCG-3'; 313-HSD forward: 5'-AGCCAATCCAGTG- 
TATGTAGGC-3', reverse:  5'-AGGTTTTCTGCTTGGCTTCCTC- 
3'; 1713-HSD type I forward: 5'-AAGTTTGCGCTCGAAGGTCTGT- 
3', reverse: 5'-TGCAGACCATCCCAATTCAGCT-3'; 13-actin forward: 
5'-GAAGATCCTGACCGAGCGTG-3', reverse: 5'-CGTACTCCT- 
GCTTGCTGATCC-3'. 
PCR was carried out using a PCR thermal cycler (model TP-3000, 
Takara). The cycle profile included denaturation for 30 s at 94°C, 
annealing for 30 s at 60°C, and extension for 60 s at 72°C. The 
amplified PCR products were electrophoresed on 1.2% agarose gels 
stained with ethidium bromide, visualized with an ultraviolet transil- 
luminator, and photographed (M085D; Poraloid, Waltham, MA). 
Real-time quantitative PCR analysis. Quantitative real-time PCR 
was used for measurement of relative mRNA expression (ABI-PRISM 
7700 Sequence Detector; PerkinElmer Applied Biosystems), according to 
our previous report, with minor modifi (15). The gene-specifi 
primers and TaqMan (FAM) probes were designed by Primer Express v. 
1.5 software (PerkinElmer Applied Biosystems). The sequences of the 
oligonucleotide were as follows: P450arom forward: 5'-CGAGATC- 
GAAATTCTGGTGGAAAAG-3', reverse: 5'-TGCAAAATCCATA- 
CAGTCTTCCAGTT-3', probe: 5'-CTGCTGAGGAAACTTT-3'; 313- 
HSD forward: 5'-GCCCAACTCCTACAAGAAGATCAT-3', reverse: 
5'-CTCGGCCATCTTTTTGCTGTATG-3', probe: 5'-ATGTGCTT- 
TCATGATGCTCT-3'; 1713-HSD type I forward: 5'-CCTGGCTCCCT- 
GGAGATACT-3', reverse: 5'-GCAGCAGCCACAGATTCC-3', probe: 
5'-TCTCTGACATCCAATTCC-3'; 13-actin forward: 5'-GGCCGG- 
GACCTGACA-3', reverse: 5'-GCTGTGGTGGTGAAGCTGTAG-3', 
probe:  5'-ACTACCTCATGAAGATCC-3'. 
Each PCR amplification was performed in triplicate using the 
following profile: 1 cycle of 95°C for 10 min and 40 cycles of 94°C 
for 15 s and 60°C for 1 min. The expression of 13-actin mRNA was 
used as an internal control. The quantitative values of P450arom, 
313-HSD, and 1713-HSD type I mRNA were normalized by that of 
13-actin mRNA expression. 
Immunoblot analysis. Tissues and cells were homogenized with 20 
mM Tris· HCl (pH 7.8), 300 mM NaCl, 2 mM EDTA, 2 mM DTT, 2% 
NP-40, 0.2% SDS, 0.2% sodium deoxycholate, 0.5 mM PMSF, 60 
µg/ml aprotinin, and 1 µg/ml leupeptin. The homogenate was gently 
rotated for 30 min at 4°C and then centrifuged at 12,000 g for 15 min 
at 4°C, and the protein concentration of the resulting supernatant was 
determined. The samples (50 µg of protein) were then subjected to 
heat denaturation at 96°C for 7 min with Laemmli buffer. Western 
blot analysis for detection of P450arom and 1713-HSD type I was 
performed according to previous reports (27, 44), with minor modi- 
fications. Briefly, each sample was separated on 10% SDS-polyacryl- 
amide gel and transferred to a polyvinylidene difluoride (Millipore, 
Billerica, MA) membrane. The membrane was then incubated in 
blocking buffer of 3% skimmed milk in phosphate-buffered saline 
containing 0.1% Tween-20 (PBS-T) for  1  h at room temperature 
followed by incubation with primary antibody, monoclonal anti- 
P450arom antibody (1:100 dilution with blocking buffer; Serotec, 
Kidlington, Oxford, UK), or polyclonal anti-1713-HSD type I (1:1,000 
dilution with blocking buffer, Santa Cruz Biotechnology, Santa Cruz, 
CA) for 12 h at 4°C. The membrane was washed with PBS-T three 
times and incubated with horseradish peroxidase-conjugated second- 
ary antibody, which was an anti-mouse IgG (1:2,000 dilution with 
blocking buffer; Amersham Biosciences, Piscataway, NJ) and an 
anti-goat IgG (1:4,000 dilution with blocking buffer, Santa Cruz 
Biotechnology), for  1  h at room temperature. After a washing as 
described above, the expression level of each molecule was detected 
by the ECL Plus system (Amersham Life Sciences), followed by 
exposure to Hyper film (Amersham Biosciences). 
Immunofluorescence  staining.  Immunofl staining  was 
performed, according to our previous report, with minor modifi 
(18). For immunohistochemical studies of P450arom, frozen tissue sam- 
ples (gastrocnemius muscle) were cut by cryostat into 10-µm sections, 
fi in acetone, and air-dried. To prevent nonspecifi staining  by 
secondary antibody, the sections were blocked with nonimmune serum 
(1% bovine albumin in Tris) for 30 min at room temperature. After an 
overnight incubation at 4°C with primary antibody, the sections were 
rinsed in phosphate buffer solution and then exposed to the fl 
secondary antibody, Cy3-conjugated Affi anti-mouse IgG or fl 
rescein-conjugated Affi rabbit anti-goat IgG (Jackson ImmunoRe- 
search Laboratories, West Grove, PA), for 2 h according to the manu- 
facturer’s instructions. The samples processed without primary antibodies 
 
 
 
 
 
       
 
 
Fig. 1. mRNA expression of steroidogenic enzymes in 
various tissues of rat. Expression of 313-hydroxysteroid 
dehydrogenase (313-HSD), 1713-hydroxysteroid dehydro- 
genase (1713-HSD) type I, and aromatase cytochrome 
P-450 (P450arom) mRNA was revealed by RT-PCR gels 
in skeletal muscle [gastrocnemius (gastro)] of the rat 
compared with positive control tissues, namely ovary, 
testis, liver, kidney, and brain. 13-Actin mRNA was used 
as an internal control. 
 
 
 
 
served as negative controls. Immunofl  images were observed 
under a Laser Scanning Confocal Imaging System (MRC-1024; Bio-Rad 
Laboratories, Hemel Hempstead, Hertfordshire, UK). In our hands, the 
intensity of aromatase immunoreactivity in frozen tissue sections was 
stronger compared with paraffi tissues. Furthermore, using 
CYP19 C-16 (Santa Cruz Biotechnology), an affinity-purifi goat poly- 
clonal antibody raised against a peptide at the carboxyl terminus of 
human CYP19, we were able to generate good immunofl 
staining. 
Sandwich EIA. Concentrations of total testosterone and estradiol in 
the skeletal muscle and muscle cell tissue extracts were determined 
using a sandwich EIA kit (total testosterone: R&D Systems, Minne- 
apolis, MN; estradiol: Cayman Chemical, Ann Arbor, MI) (9, 28, 31). 
All techniques and materials used in this analysis were in accordance 
with the manufacturer’s protocols. The immobilized antibodies were 
monoclonal raised against total testosterone and estradiol, whereas 
each secondary horseradish-peroxidase-coupled antibody was mono- 
clonal or polyclonal. Optical density was quantified on a microplate 
reader using BioLumin 960 (Molecular Dynamics, Tokyo, Japan). All 
samples were assayed in duplicate. The sensitivities of intra- and 
interassay coefficients of variation for the hormone assays were as 
follows: total testosterone 0.01–50 ng/ml, 8.9 and 9.3%, respectively; 
estradiol 0.05–1 µg/l, 5.6 and 6.1%, respectively. 
Statistics. Values are expressed as means ± SE. Statistical analyses 
of DHEA and testosterone were carried out by analysis of variance 
followed by Scheffé’s F-test for multiple comparisons. P < 0.05 was 
accepted as significant. 
 
RESULTS 
 
To investigate whether or not skeletal muscle cells possess 
steroidogenic capabilities, we examined the existence of 313- 
HSD, 1713-HSD type I, and P450arom mRNAs in skeletal 
muscle tissue (gastrocnemius) in the rat and compared their 
levels with various tissues that are known to express these 
genes, namely the ovary, testis, liver, kidney, and brain (Fig. 
1). Consistent with our hypothesis, mRNA expression of 313- 
HSD, 1713-HSD type I, and P450arom were detected in the 
skeletal muscle of rats in vivo. However, the levels of these 
genes tended to be lower in skeletal muscle than in ovary, 
testis, and brain tissues. We also sought to examine whether 
mRNA levels of steroidogenic enzymes in different skeletal 
muscle types are differentially expressed in the rat (Fig. 2). The 
mRNA level of 313-HSD in gastrocnemius was significantly 
higher than in plantaris (P < 0.05), and that of P450arom in 
soleus was significantly higher than in plantaris (P < 0.05). 
However, the mRNA level of 1713-HSD type I was not signif- 
icantly different between these fiber types. 
We sought to examine changes in protein levels of 1713-HSD 
type I and P450arom in different tissue types and skeletal 
muscle. Figure 3 shows immunoblotting data for 1713-HSD 
type I and P450arom protein expression in ovary, testis, liver, 
 
 
 
 
 
 
 
 
 
Fig. 2. mRNA expression of steroidogenic enzymes in different fiber types of 
skeletal muscle of rat. Relative expression of 313-HSD, 1713-HSD type I, and 
P450arom mRNA in different types of skeletal muscle fibers, namely slow- 
twitch (soleus), intermediate of slow- and fast-twitch (gastrocnemius), and 
fast-twitch (plantaris) fibers in the male rat (n = 10), as revealed by real-time 
quantitative PCR. 13-Actin mRNA was used as an internal control for normal- 
ization; data are expressed as means ± SE. Statistical analysis was done with 
post hoc Scheffé’s F-test for multiple comparisons. 
 
 
 
 
 
 
      
 
 
Fig. 3. Protein expression of steroidogenic enzymes in 
various tissues of rat. Representative images of immuno- 
blotting for 1713-HSD type I and P450arom protein in rat 
skeletal muscle (gastrocnemius) compared with positive 
control tissues, namely ovary, testis, liver, kidney, and 
brain. 
 
 
 
 
 
kidney, brain, and skeletal muscle (gastrocnemius) in the rat. 
Protein expressions of 1713-HSD type I and P450arom were 
detected in the skeletal muscle of rats in vivo. The levels of 
these proteins tended to be lower in skeletal muscle than in 
ovary, testis, and brain tissues in rats (Fig. 3). 
Additionally, using immunohistochemistry, we examined 
the localization pattern of P450arom protein expression in the 
skeletal muscle, which is characteristically synthesized and 
localized in the endoplasmic reticulum (Fig. 4). P450arom 
protein was localized in the cytoplasm and cytoplasmic mem- 
brane of skeletal muscle. 
To determine whether the detected steroidogenic enzymes in 
skeletal muscle were capable of generating sex steroid hor- 
mones, we measured tissue concentrations of testosterone and 
estradiol and compared them with various tissues, i.e., ovary, 
 
testis, liver, kidney, and brain (Fig. 5). We found that tissue 
concentration of testosterone in the skeletal muscle (gastroc- 
nermius) was significantly lower than in those of the ovary and 
testis (P < 0.05). Tissue concentration of estradiol in the 
skeletal muscle was also significantly lower than in those of the 
ovary (P < 0.05), whereas those were significantly higher than 
in those of liver and kidney (P < 0.05). 
We confirmed the existence of 313-HSD, 1713-HSD type I, 
and P450arom mRNAs in cultured muscle cells in vitro (Fig. 
6). Consistent with our hypothesis, mRNA expressions of 
313-HSD, 1713-HSD type I, and P450arom were detected in 
cultured muscle cells of rats in vitro. 
Finally, having detected steroidogenic enzymes in skeletal 
muscle, we sought to investigate whether skeletal muscles are 
capable of using circulating DHEA as a substrate or metabolite 
 
 
 
 
 
Fig. 4. Localization of steroidogenic enzymes protein ex- 
pression in skeletal muscle of rat. Representative images of 
immunofluorescence for P450arom in skeletal muscle (gas- 
trocnemius) of male rats (A–D). Aromatase stained red, and 
immunoreactivity is clearly seen in the cytoplasm and cy- 
toplasmic membrane (A–D) magnification (X200). E: posi- 
tive staining was also observed in blood vessels (magnifi- 
cation X200). F: omission of primary antibody showed no 
immunoreactivity in the skeletal muscle, indicating the spec- 
ificity of the antibody (magnification X200). 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Tissue levels of sex steroid hormones in various tissues of rat. Tissue 
concentrations of total testosterone and estradiol in skeletal muscle (gastroc- 
nemius) in male rats compared with positive control tissues, namely ovary, 
testis, liver, kidney, and brain (n = 10). Data are expressed as means ± SE. 
Statistical analysis was done with post hoc Scheffé’s F-test for multiple 
comparisons. 
 
 
precursor for local steroidogenesis, as previously reported in 
other peripheral tissues, by adding increasing concentration of 
DHEA or testosterone to muscles in culture (Fig. 7). Interest- 
ingly, the intracellular levels of testosterone and estradiol in 
muscle cells increased in a dose-dependent manner by addition 
of DHEA at 10 –500 µM (Fig. 7, A and B). Peak levels of 
testosterone and estradiol were seen when 500 µM DHEA was 
added; similarly, when 10 –500 µM testosterone was added, 
the intracellular levels of testosterone and estradiol in muscle 
cell increased in a dose-dependent manner (Fig. 7, C and D). 
Peak levels of testosterone and estradiol were seen when 500 
µM testosterone was added. 
DISCUSSION 
 
The present study revealed expression of mRNA of three 
steroidogenic enzymes, namely 313-HSD, 1713-HSD, and 
P450arom in the skeletal muscle cells of rats both in vivo and 
in culture (in vitro). We also demonstrated the presence of 
1713-HSD and P450arom proteins and an intracellular forma- 
tion of testosterone and estradiol from DHEA or testosterone in 
cultured muscle cell in a dose-dependent manner. These find- 
ings are novel and important in that they provide the first 
evidence showing that skeletal muscles are capable of locally 
synthesizing sex steroid hormones from circulating DHEA or 
testosterone. 
Numerous studies have previously demonstrated expression 
of steroidogenic enzymes in a variety of tissues. For instance, 
313-HSD is significantly expressed in testis, ovary, adrenal 
gland, and brain tissues (1, 49), whereas 1713-HSD is abun- 
dantly expressed in testis, ovary, adrenal gland, and brain (33, 
49), and significant levels of both the mRNA and activity of 
P450arom have been shown in ovary, gastric mucosa, tibial 
growth plate, and brain (45, 47, 49). The present study dem- 
onstrates the presence of key enzymes that locally synthesize 
testosterone and estrogen from DHEA, namely 313-HSD, 1713- 
HSD, and P450arom, in the skeletal muscle. Levels of these 
enzymes in the skeletal muscle were comparable to those found 
in the kidney and liver, implying that skeletal muscle is 
potentially an important extragonadal source of sex steroid 
hormones. 
Interestingly, we demonstrated, for the first time, a dose- 
dependent intracellular formation of testosterone and estradiol 
from DHEA or testosterone in cultured muscle cell. The 
functional significance of gonadal derived sex steroid hor- 
mones has been extensively studied; however, it is only re- 
cently that the importance of local extragonadal derived sex 
steroid hormones in cell physiology and pathophysiology is 
beginning to be appreciated in tissues such as the nervous, 
adipose, and adrenal gland (38). In the skeletal muscle cell, 
interest and evidence supporting a role for local sex steroid 
hormones, namely testosterone and estrogen, has recently been 
widely reported (16, 17, 35, 41, 43, 49). However, the exact 
source of these hormones is unclear. The present report is the 
first to clearly demonstrate presence and activity of a local 
metabolic machinery or pathway for the substrate DHEA and 
the subsequent synthesis of testosterone and estrogen in skel- 
etal muscle tissue. On the basis of earlier reports that skeletal 
muscle tissues possess receptors for both androgen (AR) and 
estrogen (ERa. and, the most recently isolated subtype, ER13) in 
various species (human, bovine, mouse, and rat) and that, as 
revealed here, they are capable of generating sex steroids 
locally, we propose the existence of a local autocrine and/or 
paracrine system of testosterone and estrogen action in skeletal 
muscle cells. The functional significance of the androgen-to- 
estrogen ratio and interaction is a concept that is increasingly 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. mRNA expression of steroidogenic enzymes in cultured muscle cells. 
Representative images showing expression of 313-HSD, 1713-HSD type I, and 
P450arom mRNA in cultured muscle cell, as revealed by RT-PCR. Rat ovary 
was used as positive control tissue, and 13-actin mRNA was used as an internal 
control. 
 
 
 
 
 
  
 
 
 
 
 
Fig. 7. Local steroidogenesis when dehydroepiandros- 
terone (DHEA) and testosterone are added in cultured 
muscle cell. Intracellular concentration of total testoster- 
one (A and C) and estradiol (B and D) formed after 
addition of either DHEA or testosterone (10, 100, 300, 
and 500 µM, respectively) in cultured muscle cell. 
Muscle cells treated with vehicle, 0.1% ethanol, were 
used as a control. Data are expressed as means ± SE of 
4 independent preparations of cells, each performed in 
triplicate (A–D). Statistical analysis was done with post 
hoc Scheffé’s F-test for multiple comparisons (control 
vs. 10, 100, 300, and 500 µM). 
 
 
 
 
      
 
becoming more important than single hormone action (7, 38). 
This ratio is thought to be controlled by aromatase, whose 
levels are regulated in a complex and tissue-specific manner. 
Admittedly, at this juncture, the functional significance of the 
androgen/estrogen ratio in the skeletal muscle is not known. 
DHEA, and DHEA-S, is the most abundant endogenous 
hormone in humans and other mammals, with 50% of the 
hormone secreted by the adrenal cortex from the classical 
biosynthetic pathway of pregnenolone and 1713-hydroxypreg- 
nenolone. The remaining 50% is synthesized by the testis, 
ovary, and brain (5). For instance, plasma DHEA-S levels in 
human adults are 100 –500 times higher than testosterone and 
1,000 –10,000 times higher than estradiol (23). Because no 
receptor for DHEA to date has been identified, it is thought to 
be more of a metabolic precursor of other steroids, such as 
testosterone and estrogen (30). Alternatively, it is believed to 
exert its influence via nongenomic mechanisms. Consistent 
with the earlier proposal, namely metabolic precursor, the 
present study demonstrates conversion of DHEA substrate to 
testosterone and estradiol by steroidogenic enzyme-expressing 
skeletal muscle cells in culture. Levels of the generated or 
synthesized hormones in vitro were much higher than those 
found in intact skeletal muscle (in vivo). This finding is in 
agreement with previous proposals suggesting that uptake of 
circulating DHEA by peripheral tissues leads to its conversion 
to testosterone and estrogens by 313-HSD, 1713-HSD, and 
P450arom (7); i.e., DHEA is converted to Ll4-androstenedione 
and Ll5-androstenediol by 313-HSD and 1713-HSD, respectively, 
which are in turn both converted to testosterone. Ultimately, 
P450arom irreversibly converts testosterone to estrogens. 
These data are important in that they reveal that circulating 
DHEA-S as well as testosterone are important substrates or 
precursors for local production of sex steroid hormones in 
skeletal muscle. 
In postmenopausal women, the secretion of estradiol by the 
ovaries is impaired, decreasing to levels comparable to those in 
men (38). This age-induced reduction in steroidogenesis in- 
creases the risk for brain, bone, and cardiovascular disorders in 
postmenopousal women (2, 4, 20). The highly effective local 
synthesis of sex steroid hormones from DHEA in skeletal 
muscle tissue, as demonstrated in the present study, would be 
helpful in differentiating the synthetic capacity of sex steroid 
hormones between the sexes or dysfunction of steroidogenesis 
by sexual organ diseases. 
The present study reveals that levels of basal mRNA of 
steroidogenic enzymes, i.e., 313-HSD and P450arom, are dif- 
ferentially expressed in different skeletal muscle type but not 
that of 1713-HSD. Slow-twitch fibers, with a rich supply of 
mitochondria, are highly dependent on oxygen and use fatty 
acids as their major energy source. On the other hand, fast- 
twitch fibers are glycolytic and movement muscles. Thus, this 
difference in gene expression of steroidogenesis-related en- 
zymes may account for differences in contractility and meta- 
bolic and vascular properties between slow- and fast-twitch 
fibers of muscle. 
Aromatase was localized in the cytoplasm of the skeletal 
muscle cells, but not in the nucleus, consistent with its ex- 
pected location, i.e., endoplasmic reticulum (8, 24). Overall, 
the detection of the three enzymes of interest by immunohis- 
tochemistry correlated with the data that we generated using 
quantitative techniques, namely Western blot and real-time 
PCR analysis. These techniques revealed significant levels of 
protein and gene expression comparable to those reported 
previously, including PCR (13), immunoblot analysis, immu- 
nofluorescence staining, and EIA (18). Importantly, the fact 
that the protein levels of these enzymes and concentrations of 
the respective hormones that they synthesize were strikingly 
similar, as revealed by enzyme immunoassay, implies that they 
are not only transcribed and translated locally but are function- 
ally active. On Western blots, we detected distinct bands for 
each enzyme, with molecular masses that were very close to 
the values previously reported for other tissues, i.e., 34.5 kDa 
for 1713-HSD and 53–55 kDa for P450arom in rat seminiferous 
tubules, crude germ cells (26), and human testicular cell lines 
(6) for P450arom. 
DHEA-S is activated to DHEA after hydrolysis of the sulfate 
group by the microsomal enzyme steroid sulfatase. Thus ste- 
roid  sulfatase  is  the  key  enzyme  with  important  roles  for 
 
 
 
 
 
 
steroid metabolism. Further studies should examine the gene 
expression of steroid sulfatase in skeletal muscles and 
P450arom, which plays an important role in sex steroid me- 
tabolism of both males and females. In our next studies, we 
plan to investigate whether females are capable of generating 
steroids in their muscles. Finally, it is important to state that 
caution in extrapolating the present data to humans should be 
exercised, because circulating levels of DHEA and DHEA-S in 
rodents are lower than in humans. Future studies need to 
investigate whether human muscle tissue or cells in culture are 
steroidogenically competent as in rodents, which potentially is 
of great interest in that it may have implications in hormone 
therapy and perhaps in sports. 
In conclusion, the novel findings of the present study, 
demonstrating for the first time the presence of local and active 
metabolic machinery or pathway (mRNA and protein expres- 
sions of 313-HSD, 1713-HSD, and P450arom) for synthesis of 
sex steroid hormones (testosterone and estrogen) from circu- 
lating DHEA in the skeletal muscle cells, provides further 
evidence for the presence of an autocrine/paracrine system for 
sex steroid hormones and their roles in skeletal muscle function 
and adaptation. 
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